Trial Profile

A Pilot, Multiple Dose Study to Evaluate the Efficacy and Safety of MRx-4DP0004 in Hospitalised Patients With Symptoms of COVID-19 (SARS-CoV-2 Infection)

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 18 Jun 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MRx 4DP0004 (Primary)
Indications COVID 2019 infections; Respiratory tract disorders
Focus Therapeutic Use
Sponsors 4D Pharma PLC

Most Recent Events

11 Jun 2021 Planned End Date changed from 1 Sep 2020 to 1 Jan 2021.
11 Jun 2021 Planned primary completion date changed from 1 Aug 2020 to 1 Dec 2020.
11 Jun 2021 Planned initiation date changed from 1 May 2020 to 1 Aug 2020.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com